SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-201317
Filing Date
2024-08-15
Accepted
2024-08-15 16:09:05
Documents
51
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 6-K d625590d6k.htm   iXBRL 6-K 81373
2 EX-99.1 d625590dex991.htm   iXBRL EX-99.1 500070
3 EX-99.2 d625590dex992.htm EX-99.2 92196
4 EX-99.3 d625590dex993.htm EX-99.3 89383
  Complete submission text file 0001193125-24-201317.txt   3032399

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ncna-20240630.xsd EX-101.SCH 28179
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ncna-20240630_cal.xml EX-101.CAL 34410
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ncna-20240630_def.xml EX-101.DEF 70885
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ncna-20240630_lab.xml EX-101.LAB 194124
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ncna-20240630_pre.xml EX-101.PRE 155876
53 EXTRACTED XBRL INSTANCE DOCUMENT d625590d6k_htm.xml XML 496168
Mailing Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT
Business Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT 44-0-131-357-1111
NuCana plc (Filer) CIK: 0001709626 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38215 | Film No.: 241212494
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)